Enumeration of lines of therapy (LoT) is critical across oncology for ensuring optimal patient care, establishing uniform eligibility for clinical trial enrolment, standardising use of real-world data (RWD), and pooling data for research purposes. Building on an earlier proposal for assigning LoT in oncology, the European Society for Medical Oncology (ESMO) developed the ESMO adaptation of Lines of Systemic Therapy…
ESMO Adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumours
Annals of Oncology | | K.S. Saini, M. Koopman, D. Martins-Branco, P. Bossi, S.Braendegaard Winther, M. Brahmi, I. Braña, E. Calvo, L. Castelo-Branco, I. Colombo, E. de Azambuja, D. De Ruysscher, R. Dienstmann, A-M.C. Dingemans, M. Ekholm, C. Gallois, V. Golfinopoulos, E. Grande, S. Halabi, E. Le Rhun, O. Le Saux, N.B. Leighl, S. Lonardi, S. Lorenzen, D. Lorusso, Giuseppe Minniti, G. Mountzios, J. Oldenburg, S.F. Oosting, P. Osterlund, J.L. Perez-Gracia, A. Pellat, S. Piperno-Neumann, R. Plummer, C. Porta, K. Punie, I. Ray-Coquard, J. Remon, C.H. Ruhlmann, P. Rutkowski, L.L. Siu, S. Stacchiotti, C. Suarez, K. Suijkerbuijk, J. Taieb, D. Trapani, A. Valachis, H.W.M. van Laarhoven, A. Vogel, A. Zer, G. Pentheroudakis, S. Delaloge, C. Twelves
Topics: clinical-trials, research